Major congenital malformations and antiepileptic drugs: prospective observations
- PMID: 16421112
- PMCID: PMC2077593
- DOI: 10.1136/jnnp.2005.079376
Major congenital malformations and antiepileptic drugs: prospective observations
Abstract
High dose lamotrigine may be teratogenic
Conflict of interest statement
Competing interests: The author is a Member of Scientific Advisory Board for the European Pregnancy Registry (EURAP)
Comment on
-
Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register.J Neurol Neurosurg Psychiatry. 2006 Feb;77(2):193-8. doi: 10.1136/jnnp.2005.074203. Epub 2005 Sep 12. J Neurol Neurosurg Psychiatry. 2006. PMID: 16157661 Free PMC article.
References
-
- Meadow S R. Antiepileptic drugs and congenital abnormalities. Lancet 19682196 - PubMed
-
- Penovich P, Gaily E. What can we say to women of reproductive age with epilepsy? Neurology 200564938–939. - PubMed
-
- Cunnington M, Tennis P and International Lamotrigine Pregnancy Registry Scientific Advisory Committee Lamotrigine and the risk of malformations in pregnancy. Neurology 200564961–965. - PubMed
-
- Tomson T, Perucca E, Battino D. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy. Epilepsia 2004451171–1175. - PubMed